Xgeva 120 mg Xgeva 120 mg/1.7 mL contains Denosumab, a monoclonal antibody that helps protect bones from damage caused by cancer. It works by blocking a protein responsible for excessive bone breakdown, reducing the risk of fractures and other serious bone-related complications. Xgeva is administered by a healthcare professional and is commonly used in patients with cancers that have spread to the bones.